Copyright
©The Author(s) 2024.
World J Psychiatry. Sep 19, 2024; 14(9): 1308-1318
Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1308
Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1308
Table 1 Demographic and clinical characteristics, n (%)
Index | Control group | Generalized anxiety disorder group | t/χ2 | P value |
Age (yr) | 53.79 ± 16.23 | 58.30 ± 13.70 | 1.863 | 0.065 |
Sex (male/female) | 25/45 | 39/50 | 1.812 | 0.178 |
Body mass index (kg/m2) | 24.55 ± 2.06 | 24.46 ± 3.24 | 0.291 | 0.760 |
Smoking history | 19 (27.14) | 18 (20.22) | 1.050 | 0.305 |
Drinking history | 9 (12.85) | 8 (8.99) | 0.001 | 0.529 |
Diabetes | 10 (14.29) | 13 (14.60) | 0.030 | 0.954 |
Hypertension | 33 (47.14) | 46 (51.69) | 0.323 | 0.570 |
Coronary heart disease | 8 (11.42) | 18 (20.22) | 2.216 | 0.137 |
Hyperlipidemia | 7 (10.00) | 10 (11.23) | 0.063 | 0.802 |
Cerebral infarction | 10 (14.28) | 15 (16.85) | 0.195 | 0.659 |
Table 2 Comparison of levels of inflammation-related cytokines between the two groups
Inflammatory factor (normal range) | Control group (mean ± SD) | Generalized anxiety disorder group (mean ± SD) | t value | P value |
IL-1β (0-12.4 pg/mL) | 1.69 ± 1.04 | 1.96 ± 2.21 | 1.024 | 0.308 |
IL-2 (0-5.71 pg/mL) | 1.45 ± 0.98 | 1.78 ± 1.40 | 1.684 | 0.094 |
IL-4 (0-3 pg/mL) | 1.68 ± 1.14 | 2.19 ± 1.82 | 2.040 | 0.043 |
IL-5 (0-3.10 pg/mL) | 1.27 ± 0.58 | 2.18 ± 1.80 | 4.044 | 0.001 |
IL-6 (0-7 pg/mL) | 5.03 ± 3.11 | 5.06 ± 3.98 | -0.40 | 0.968 |
IL-8 (0-20.60 pg/mL) | 30.59 ± 41.33 | 57.53 ± 230.29 | 1.081 | 0.336 |
IL-10 (0-4.91 pg/mL) | 2.30 ± 0.82 | 3.66 ± 5.86 | 2.163 | 0.056 |
TNF-α (0-4.60 pg/mL) | 2.05 ± 1.25 | 2.42 ± 2.67 | 1.069 | 0.287 |
IFN-γ (0-7.42 pg/mL) | 1.77 ± 1.29 | 2.02 ± 1.59 | 1.056 | 0.292 |
IL-17A (0-20.6 pg/mL) | 7.23 ± 4.84 | 4.27 ± 4.42 | -3.749 | 0.001 |
IL-12p70 (0-3.4 pg/mL) | 2.07 ± 1.40 | 2.55 ± 2.54 | 1.443 | 0.151 |
IFN-α (0-8.5 pg/mL) | 1.80 ± 1.20 | 3.42 ± 10.42 | 1.460 | 0.148 |
Table 3 Inflammation-related cytokine levels after lipopolysaccharide stimulation
Inflammatory factor (normal range) | Control group (mean ± SD) | Generalized anxiety disorder group (mean ± SD) | t value | P value |
IL-1β (0-12.4 pg/mL) | 1592.06 ± 622.43 | 1538.99 ± 844.21 | -0.440 | 0.660 |
IL-2 (0-5.71 pg/mL) | 1.12 ± 0.67 | 1.13 ± 0.85 | 0.082 | 0.935 |
IL-4 (0-3 pg/mL) | 1.44 ± 0.75 | 1.25 ± 0.77 | -1.568 | 0.119 |
IL-5 (0-3.10 pg/mL) | 1.09 ± 0.68 | 1.04 ± 0.39 | -0.625 | 0.534 |
IL-6 (0-7 pg/mL) | 14354.85 ± 1420.62 | 14657.66 ± 3347.42 | 0.173 | 0.443 |
IL-8 (0-20.60 pg/mL) | 9515.79 ± 3803.61 | 11351.12 ± 6349.79 | 2.306 | 0.025 |
IL-10 (0-4.91 pg/mL) | 1244.80 ± 2727.53 | 1049.45 ± 2877.97 | -0.433 | 0.665 |
TNF-α (0-4.60 pg/mL) | 2666.29 ± 1272.87 | 3197.81 ± 1887.78 | 1.676 | 0.045 |
IFN-γ (0-7.42 pg/mL) | 34.72 ± 166.81 | 23.77 ± 74.81 | -0.553 | 0.581 |
IL-17 (0-20.6 pg/mL) | 26.91 ± 22.767 | 28.78 ± 30.53 | 0.426 | 0.671 |
IL-12p70 (0-3.4 pg/mL) | 2.50 ± 2.84 | 1.94 ± 1.44 | -1.633 | 0.104 |
IFN-α (0-8.5 pg/mL) | 2.42 ± 2.24 | 2.01 ± 2.21 | -1.181 | 0.240 |
Table 4 Correlation between inflammatory factors and Hamilton Anxiety Rating Scale scores
Inflammatory factor | Correlation with HAMA scores before LPS stimulation | Correlation with HAMA scores after LPS- stimulation | ||
r value | P value | r value | P value | |
IL-1β | 0.118 | 0.271 | 0.219 | 0.039 |
IL-2 | 0.131 | 0.220 | -0.20 | 0.852 |
IL-4 | 0.106 | 0.322 | 0.663 | 0.558 |
IL-5 | -0.087 | 0.420 | -0.042 | 0.698 |
IL-6 | 0.058 | 0.590 | 0.379 | < 0.001 |
IL-8 | 0.149 | 0.164 | 0.640 | < 0.001 |
IL-10 | 0.050 | 0.640 | -2.92 | 0.005 |
TNF-α | 0.108 | 0.313 | 0.621 | < 0.001 |
IFN-γ | 0.049 | 0.647 | 0.153 | 0.151 |
IL-17A | 0.245 | 0.021 | 0.138 | 0.197 |
IL-12p70 | 0.118 | 0.270 | 0.091 | 0.399 |
IFN-α | 0.036 | 0.737 | 0.144 | 0.178 |
Table 5 Correlation between inflammatory factors and mental anxiety and somatic anxiety
Inflammatory factor | Correlation with mental anxiety | Correlation with somatic anxiety | ||
r value | P value | r value | P value | |
IL-1β | 0.148 | 0.166 | 0.236 | 0.026 |
IL-6 | 0.374 | < 0.0001 | 0.304 | 0.004 |
IL-8 | 0.495 | < 0.0001 | 0.587 | < 0.0001 |
IL-10 | -0.224 | < 0.035 | -0.307 | 0.003 |
TNF-α | 0.644 | < 0.0001 | 0.503 | < 0.0001 |
Table 6 Correlation between inflammatory factors and factors of somatic anxiety
Somatic anxiety factor (symptoms) | Correlation with inflammatory factors | |||||
IL-1β | IL-8 | IL- 10 | ||||
r value | P value | r value | P value | r value | P value | |
Muscular system | 0.26 | 0.808 | 0.175 | 0.101 | -0.20 | 0.853 |
Sensory system | 0.143 | 0.182 | 0.114 | 0.288 | -1.69 | 0.114 |
Cardiovascular system | 0.30 | 0.004 | 0.119 | 0.265 | 0.029 | 0.788 |
Respiratory system | 0.012 | 0.908 | 0.118 | 0.273 | -0.092 | 0.392 |
Gastrointestinal system | -0.052 | 0.630 | 0.027 | 0.801 | -0.503 | < 0.0001 |
Genitourinary system | 0.102 | 0.341 | 0.322 | 0.002 | -0.124 | 0.245 |
Autonomic nervous system | 0.077 | 0.471 | 0.517 | < 0.0001 | -0.040 | 0.707 |
- Citation: Wang WY, Liu N, Qi XX, Han B, Sun JN, Chen ZL, Wang MW, Wang YY. Predictive effect of lipopolysaccharide-stimulated inflammatory cytokines on symptoms of generalized anxiety disorder. World J Psychiatry 2024; 14(9): 1308-1318
- URL: https://www.wjgnet.com/2220-3206/full/v14/i9/1308.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i9.1308